Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA Securities
October 18, 2021 6:25 AM
BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $55.00 (from $56.00) while maintaining a Buy rating.
